Lecture one: Patient Assessment in Pharmacy Practice
-
Upload
anas-bahnassi- -
Category
Education
-
view
2.787 -
download
3
description
Transcript of Lecture one: Patient Assessment in Pharmacy Practice
Patient Care in Pharmacy Practice
Anas Bahnassi PhD
Anas Bahnassi PhD CDM CDE 2
Patient-Centered Care
Care centered on patients’ needs and expectations
3Anas Bahnassi PhD CDM CDE
Goals of Pharmaceutical Care
Cure of a disease
Elimination or reduction of a patient’s symptoms
Arresting or slowing of a disease process
Preventing a disease or symptomatology
4Anas Bahnassi PhD CDM CDE
The central component of Pharmaceutical Care is: CARING ABOUT THE PATIENT.
5Anas Bahnassi PhD CDM CDE
Pharmaceutical Care Process
Initiate relationship with
the patient or caregiver
Gather patient information
(subjective and objective) Assess info
(patient assessment)
Develop pharmaceutical
care plan
Complete InterventionImplement
follow-up
6Anas Bahnassi PhD CDM CDE
Primary Elements of Pharmaceutical Care
The need of the society to address Drug
Related Problems (DRPs) A patient-centered
approach to meet this need
A practice based on “caring”
about and for patients
Responsibility for finding and
responding to the patient’s DRPs
7Anas Bahnassi PhD CDM CDE
Pharmacist responsibility inPharmaceutical Care
To ensure that the patient’s drug therapy is appropriately indicated, the most effective available, the safest possible, the most convenient to take, and the most economical
To identify, resolve, and prevent any DRPs
To ensure that the patient’s therapeutic goals are met and that optimal health-related outcomes are attained.
8Anas Bahnassi PhD CDM CDE
Drug Related ProblemsDRPs
– To resolve identified DTPs and to prevent future problems, pharmacist must understand the causes of these problems.
– The pharmacist must use a consistent, systematic and comprehensive process Pharmaceutical Care process
DRP is any undesirable event experienced by the patient that involves drug therapy and that actually (or potentially) interferes with a desired patient outcome.
9Anas Bahnassi PhD CDM CDE
Common DRPs and Their causesDRP Type Possible CausesUnnecessary Drug Prescribed
No IndicationDuplicate Therapy
Wrong Drug Contraindications presentDrug not indicated for conditionsMore effective medic. availableDrug interactionIndication refractory to drugInappropriate dosage form
Dose Too Low Wrong doseInappropriate frequencyInappropriate durationIncorrect storageIncorrect administrationDrug interaction 10Anas Bahnassi PhD CDM CDE
Common DRPs and Their causesDRP Type Possible CausesDose Too High Wrong dose
Inappropriate frequencyInappropriate durationIncorrect administrationDrug interaction
Adverse Drug Reactions Undesirable drug side effectAllergic reactionDrug interactionIncorrect administrationDose changed too quicklyUnsafe drug for the patient
11Anas Bahnassi PhD CDM CDE
Common DRPs and Their causesDRP Type Possible CausesNoncompliance Cannot afford drug
Doesn’t understand instructions on how to take the drugCannot swallow/administer the drugDrug not available
Additional drug therapy Untreated conditionProphylactic therapySynergistic therapy
12Anas Bahnassi PhD CDM CDE
Pharmaceutical CareProcess• Initiating a relationship with the patient
– patient bringing a new prescription to the pharmacy or asking about a nonprescription drug
• Pharmacist gathers all the pertinent information to evaluate the patient’s health and drug therapy appropriately– subjective information (patient complaints and
symptoms)– objective information (medication profile, vital signs,
or physical assessment data)
13Anas Bahnassi PhD CDM CDE
Pharmaceutical CareProcess• Pharmacist assess the information and looks for
DRPs. • The DTPs are prioritized along with corresponding
goals and goal criteria, and documented in pharmaceutical care plan (PCP)
• Integral to the PCP, pharmacist develop the solutions to DRPs (= interventions).
• Develop the monitoring plan, which outlines factors that will determine attainment of the desired patient outcomes (BP measurement, lab data, talking with patient).
14Anas Bahnassi PhD CDM CDE
Pharmaceutical CareProcess• Implement follow-up, which includes
implementing the monitoring plan (ex. Contact the patient to evaluate drug therapy compliance or drug side effects). Other follow up may include measuring vital signs or checking other physical or lab data.
NOTE:• Ideally, the patient should be involved throughout the entire
pharmaceutical care process.• After that plan has been implemented, the PCP recycles once again. The
pharmacist gather more data, assess the Px progress, and adjust the plan.
15Anas Bahnassi PhD CDM CDE
For successfully incorporate Pharmaceutical Care into Practice, the Pharmacist
must have knowledge and skills in Patient
Assessment
16Anas Bahnassi PhD CDM CDE
Patient Assessment
Patient assessment is the process through which the pharmacist evaluate the patient information (both objective and subjective) that was gathered from the patient and other sources (e.g. drug therapy profile, medical record, etc.)
17Anas Bahnassi PhD CDM CDE
Patient AssessmentMeans:
Making decisions regarding:
1. The health status of the patient.
2. Drug therapy needs and problems.
3. Interventions that will resolve identified drug problems and future problems
4. Follow-up to ensure that patient outcomes are being met.
18Anas Bahnassi PhD CDM CDE
Purpose of Patient Assessment:
A pharmacist cannot adequately provide pharmaceutical care without assessing patients.
• To identify, • To resolve, and • To prevent drug
related problems.
19Anas Bahnassi PhD CDM CDE
Patient Assessment Should be done by:
• Asking a series of questions:• These questions will guide the pharmacist
through the assessment process.
• Assess the patient’s physical conditions:
• e g. skin abnormalities, obtainment of vital signs, peak flow readings, blood glucose levels, cholesterol values.
20Anas Bahnassi PhD CDM CDE
Documentation:
• Provides a permanent record of patient information.
• Provides a permanent record and evidence of pharmaceutical care activities by the pharmacist.
• Communicates essential information to other pharmacists and health care professionals.
• Serves as a legal record of patient care that was provided.
• Provides back-up for billing purposes.
21Anas Bahnassi PhD CDM CDE
Characteristics ofUseful Patient Records:• Information that is neat, organized, and able to be found
quickly.• Information that is easily understandable, so that any health
care professional can determine what the problems were, what actions were taken, and what follow-up is needed.
• Accurate subjective and objective information.• An assessment of the patient
information, focusing on DRPs.• A plan to resolve any problems that
were identified.• A plan for future follow-up to ensure that any problems are
resolved and that patient outcomes are met.22Anas Bahnassi PhD CDM CDE
SOAP Note
23Anas Bahnassi PhD CDM CDE
SOAP Note:
Subjective:Includes information that is given by the patient, family members, significant others, orcare givers.
• Complaint/symptoms in his/her own words
• Recent history that pertains tithose symptoms (history of present illness)
• Past medical history• Medication history, including
compliance & ADRs.• Allergies• Social and/or family history• Review of systems.
This type of information contains:
24Anas Bahnassi PhD CDM CDE
SOAP Note:
Objective:Includes data that are obtained from the patient and that can be measured objectively.
• Vital signs.• Physical findings or physical
examination (if possible).• Laboratory test results (if
available).• Serum drug concentrations (if
available).• Various diagnostic test results (if
available).• Computerized medication profile
with refill information (if available).
This type of information contains:
25Anas Bahnassi PhD CDM CDE
SOAP Note:
Assessment:
• Analyzes subjective and objective information.
• Determines the health status of the patient.• Is the patient experiencing a
DRP?• Have the patient’s outcomes
been met?• Provides the basis and rationale
for the plan.
The pharmacist:
26Anas Bahnassi PhD CDM CDE
SOAP Note:
Plan:• Actions that were—or need to be—
taken to resolve any problems that have been identified.
• Follow-up to ensure that problems are actually corrected and that future problems do not develop.• The follow-up should include
monitoring parameters that need to be assessed as well as the interval for the next assessments
It involves:
27Anas Bahnassi PhD CDM CDE
SOAP Note:
Plan:• Guidelines should be done with
the data at the time of the follow-up.
• Simplicity and reproducibility:• A colleague should be able to
read, interpret, and act on the plan if the pharmacist who documented the note is not available.
It involves:
28Anas Bahnassi PhD CDM CDE
PharmaceuticalCare Plan:
Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID
• The patient is picking up her Atenolol Rx.
• She feels:• Head lightness.• Weakness.• Impaired balance for 2 weeks.
• She has been taking Atenolol BID instead of QD this week.
Subjective:
29Anas Bahnassi PhD CDM CDE
PharmaceuticalCare Plan:
Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID
• The patient was staggering at the pharmacy counter.• Pulse is: 48 bpm.• Blood pressure is:
114/72 mm Hg112/70 mm Hg
Objective:
30Anas Bahnassi PhD CDM CDE
PharmaceuticalCare Plan:
Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID
• Bradycardia and hypotension-new-onset may be due noncompliance with atenololdosing.
Assessment:
31Anas Bahnassi PhD CDM CDE
PharmaceuticalCare Plan:
Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID
• Inform the patient to take atenolol once a day with breakfast and captopril 2 times daily as usual.
• For the follow-up a week later recheck pulse and blood pressure. • If still low, ask her to contact
her doctor and suggest lowering the dose atenolol.
Plan:
32Anas Bahnassi PhD CDM CDE
Clinical Pharmacy VI:First AidAnas Bahnassi PhD CDM CDE
http://www.twitter.com/abpharm
http://www.facebook.com/pharmaprof
http://www.linkedin.com/in/abahnassi